Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 8

Results For "ISA"

1046 News Found

Caplin Point Lab's subsidiary receives nod from Brazil's ANVISA for sterile injectable manufacturing site
Drug Approval | August 17, 2021

Caplin Point Lab's subsidiary receives nod from Brazil's ANVISA for sterile injectable manufacturing site

The approval allows it to market its products in the country


Roche receives emergency use authorisation of COVID-19 drug
News | May 07, 2021

Roche receives emergency use authorisation of COVID-19 drug

This Emergency Use Authorisation will now enable Roche to import the globally manufactured product batches to India


Briefs: Hikal and Sun Pharma
Drug Approval | June 17, 2025

Briefs: Hikal and Sun Pharma

Sun Pharma gets 8 observations from USFDA for Halol facility


Sun Pharma appoints Kirti Ganorkar as the Managing Director
People | June 13, 2025

Sun Pharma appoints Kirti Ganorkar as the Managing Director

Dilip Shanghvi to continue as the Executive Chairman of the Board


Biocon Foundation launches BioWISE Program to empower women in STEM
News | June 11, 2025

Biocon Foundation launches BioWISE Program to empower women in STEM

25 women students to receive internship, training, and mentorship in Life Sciences segment


Cadila launches beta-blocker Biscado for treatment of cardiovascular diseases
News | June 10, 2025

Cadila launches beta-blocker Biscado for treatment of cardiovascular diseases

Bisoprolol is a highly cardioselective beta-1 adrenergic blocker used to manage high blood pressure,


Fujifilm rebrands life sciences companies to strengthen position as strategic partners for life
News | June 07, 2025

Fujifilm rebrands life sciences companies to strengthen position as strategic partners for life

Enhanced alignment to better serve customers across the entire drug development lifecycle under the Fujifilm Life Sciences brand umbrella with the tagline Partners for Life


Biocon gets approval for diabetes drug Liraglutide in India
Diagnostic Center | June 03, 2025

Biocon gets approval for diabetes drug Liraglutide in India

The approval is for the generic version of Victoza, indicated for the treatment of insufficiently controlled Type 2 Diabetes Mellitus


Sigachi Industries FY25 revenue surges 25%, EBITDA 46%
News | June 02, 2025

Sigachi Industries FY25 revenue surges 25%, EBITDA 46%

Newly commissioned MCC in Jhagadia and Dahej and CCS project expansions will unlock an additional 8,800 MTPA, fuelling year-over-year revenue gains of 20%-30% in excipients